Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 591 Neoplasms 296 Carcinoma, Non-Small-Cell Lung 286 Prostatic Neoplasms 266 Colorectal Neoplasms 213 Multiple Myeloma 182 Lung Neoplasms 150 Neoplasm Metastasis 139 Leukemia, Myeloid, Acute 126 Leukemia 120 Lymphoma 114 Lymphoma, Follicular 113 Stomach Neoplasms 105 Lymphoma, Non-Hodgkin 102 Colonic Neoplasms 98 Ovarian Neoplasms 96 Rectal Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Uterine Cervical Neoplasms 93 Head and Neck Neoplasms 92 Leukemia, Lymphocytic, Chronic, B-Cell 91 Pain 90 Carcinoma, Hepatocellular 86 Pancreatic Neoplasms 81 Melanoma 78 Lymphoma, Large B-Cell, Diffuse 77 Papillomavirus Infections 68 Recurrence 66 Squamous Cell Carcinoma of Head and Neck 64 Parkinson Disease 4, Autosomal Dominant Lewy Body 63

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × ENT Cancer × Clear all

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡